| Literature DB >> 35515815 |
M A Sacco1,2, A Zibetti1,2, C F Bonetta1,2, C Scalise1,2, L Abenavoli1,2, F Guarna1,2, S Gratteri1,2, P Ricci1,2, I Aquila1,2.
Abstract
Kambo is the name of a natural substance derived from the glandular secretions of the amphibian Phyllomedusa bicolor, a species native to regions in South America. The communities living in these areas administer the substance generally transdermally during rituals for religious-purifying purposes, producing small skin burns. The scientific literature has reported some cases of intoxication following the use of Kambo but this aspect is still poorly understood. In fact, no shared therapy protocols exist for these events nor any real legislation on Kambo. The purpose of this work was to examine all cases of acute intoxication resulting from the administration of Kambo and published over the last 10 years, illustrating clinical signs, laboratory findings, instrumental tests, and therapy. The several cases identified in our review confirm that acute Kambo intoxication can occur, with serious and life-threatening effects. We developed a protocol aimed at the early diagnosis of cases of suspected acute intoxication by creating a treatment algorithm. The study aims to investigate the pathophysiology of these events in humans, proposing a protocol for the diagnosis and treatment of these cases that can be used by healthcare professionals.Entities:
Keywords: Forensic toxicology; Intoxication; Kambo; Phyllomedusa bicolor; Sapo
Year: 2022 PMID: 35515815 PMCID: PMC9061256 DOI: 10.1016/j.toxrep.2022.04.005
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Results of the literature review (part one).
| Robalino Gonzaga et al. | Alamos et al. | de la Vega et al. | Campodónico et al. | Agüero-González et al. | Roy et al. | Kumachev et al. | Li et al. | Aquila et al. | Pogorzelska et al. | Leban et al. | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | F | F | F | F | F | F | F | F | M | M | F |
| Age | 62 | 41 | 33 | 41 | 33 | 32 | 24 | 42 | 34 | 44 | |
| Weight | 88 | Overweight | 72 | ||||||||
| Comorbidity | Depression, alcohol, and nicotine dependence | Depression | None | Hypothyroidism, personality disorder | None | None | Moderate coronary atheroma, left ventricular hypertrophy | Previous consumption of alcohol and cannabis | None | ||
| Onset of symptoms after administration | Few minutes | 12 h | 6 h | 1 h | 30 min | 3 h | |||||
| Site of administration | Skin (ointment) | Leg | Shoulder | arm | leg | Arm and heel | Ankle | arm | Abdomen-back | Shoulder | |
| Water intake after administration | 6 litres | 3,5 litres | 4 litres | ||||||||
| Type of consumer | Occasional | Chronic | Occasional | Occasional | chronic | Cronic | chronic | Occasional | |||
| Identification of the substance at toxicological screening | No | No | No | No | yes | No | |||||
| Toxicological findings | +BDZ | + cannabinoids | + cannabinoids | + deltorphin A | |||||||
| Tachycardia | Yes | yes | No | No | yes | ||||||
| Heart rate | 110 bpm | 60 | 82 | 90 | |||||||
| Blood pressure (mmHg) | 110/74 | 92/55 | 112/85 | 160/100 | |||||||
| Respiratory rate (min) | 14 | 26 | 20 | ||||||||
| O2 saturation | 96 | 100 | |||||||||
| Temperature | Yes | ||||||||||
| Dyspnea | Yes | Yes | |||||||||
| Nausea | yes | yes | yes | yes | yes | yes | yes | ||||
| Abdominal discomfort | yes | yes | yes | ||||||||
| Results of the literature review (part two) | |||||||||||
| Vomit | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||||
| Diarrhea | Yes | ||||||||||
| Muscle ailments | Yes | Yes | Yes | Yes | Yes | ||||||
| Rhabdomyolysis | Yes | Yes | Yes | ||||||||
| Psychiatric disorders | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||||
| Epilepsy | Yes | Yes | Yes | Yes | Yes | ||||||
| Muscle markers | Elevate | Elevate | Elevate | Elevate | Elevate | ||||||
| Transaminases | Elevate | Elevate | Elevate | Elevate | |||||||
| Leukocytosis | Yes | Yes | Yes | ||||||||
| Lactic acidosis | Yes | Yes | |||||||||
| pH | 7.52 | 7.38 | |||||||||
| LDH | Elevate | ||||||||||
| Amylase | Normal | ||||||||||
| Lipase | Normal | ||||||||||
| Natremia | Reduced | Reduced | Reduced | ||||||||
| Kaliemia | Reduced | Reduced | Reduced | ||||||||
| Magnesemia | Reduced | ||||||||||
| Phosphatemia | Reduced | ||||||||||
| Number of platelets | Reduced | ||||||||||
| CT / MRI investigation | Pneumothorax, pneumomediastinum and pleural effusions | Normal brain imaging | Normal brain imaging | Normal brain imaging | No evidence of abnormalities on brain imaging (CT) | ||||||
| EEG | Normal | Altered | Altered | ||||||||
| EMG | Altered | ||||||||||
| Related pathology | Rupture of gullet from severe vomiting | Acute renal failure | Dermatomyosis | Syndrome of Inappropriate ADH Secretion (SIADH) | Syndrome of Inappropriate ADH Secretion (SIADH) | Psychosis | Acute gastrointestinal poisoning | Syndrome of Inappropriate ADH Secretion (SIADH) | Death secondary to acute heart failure | Toxic hepatitis | Syndrome of Inappropriate ADH Secretion (SIADH) |
| Duration of symptoms | 7 days | 3 months | 7 days | 5 days | 9 days | 1 h | 1 day | 10 days | Three days | ||
| Therapy | Surgical intervention | Mechanical ventilation, Valproic acid, Hydration | Prednisone | Dexmedetomidine, Sodium bicarbonate, Reduction in water intake | Midazolam, Calcium Gluconate, Magnesium Sulphate, Potassium Chloride, Dexmedetomidine | Risperidone | Ondansetron, Ketorolac, Naloxone | Haloperidol, diphenhydramine, Lorazepam | Lactulose, Silymarin, Ornithine | Diazepam, Sodium chloride 0.9%, Water restriction | |
Features of acute intoxication cases in the reviewed literature.
| Number of cases | Sex | Age range | Mage | Systems affected by signs/ symptoms | Related pathologies |
|---|---|---|---|---|---|
| Acute poisoning | M:F = 2:9 | 24–62 years | 38,6 years | Gastrointestinal system = 8 | Syndrome of Inappropriate ADH Secretion: 5 |
Toxicological examination, collection and storage of samples.
| Collection of biological material on living beings | Collection of biological material from corpse | Method of conservation | Instrumental examination | Main families of bioactive peptides to be researched |
|---|---|---|---|---|
| Peripheral blood | Peripheral blood | -80 °C | Mass spectrometry | Bradykinins |
Peptides’formula and pharmacodynamics.
Protocol for early diagnosis and treatment of cases of suspected acute intoxication by Kambo.